Xarelto is an oral anticoagulant that selectively inhibits factor xa. By blocking factor xa it prevents the conversion of prothrombin to thrombin. The reduction in thrombin generation limits the formation of fibrin polymers. This action decreases the propensity for thrombus development in the venous system and arterial circulation. Clinically it is used to prevent stroke in patients with atrial fibrillation and to treat deep vein thrombosis. It also serves as prophylaxis for pulmonary embolism in high-risk patients following surgery. The drug's pharmacodynamic effect is a dose-dependent prolongation of the clotting time without directly affecting platelets.

Xarelto is a direct oral anticoagulant that inhibits factor xa in the coagulation cascade. By blocking this enzyme it prevents the formation of thrombin and reduces clot development. This pharmacodynamic effect leads to a measurable prolongation of clotting time in patients. The drug is absorbed orally and reaches peak plasma concentrations within a few hours. It is eliminated primarily through renal excretion with a half-life of approximately eight hours. Xarelto is prescribed to treat and prevent venous thromboembolism and to reduce stroke risk in atrial fibrillation. Its selective inhibition of factor xa provides consistent anticoagulation without requiring routine laboratory monitoring. The medication's mechanism relies on binding to the active site of factor xa and thereby interrupting downstream fibrin formation.

Xarelto is an oral anticoagulant used to prevent blood clots. Common side effects include bleeding bruising and prolonged bleeding from cuts. Some patients may experience dizziness or headaches. Rarely gastrointestinal discomfort such as nausea or abdominal pain can occur. Infections are uncommon but can present with fever or chills. Liver function may be affected in certain individuals leading to fatigue or dark urine. Patients should monitor for signs of excessive bleeding such as blood in urine or stool. Overall the medication is generally safe when used as prescribed.

Xarelto can cause bleeding in various organs including the gastrointestinal tract. It may increase the likelihood of bruising or prolonged bleeding from minor cuts. Some users experience dizziness or headache as side effects. Rarely the drug can lead to elevations of liver enzymes. Swelling in the legs or shortness of breath has been reported in some patients. The frequency and severity of these effects can differ among individuals.